Diagnosis and grading of cervical intraepithelial neoplasias;Diagnose und graduierung zervikaler intraepithelialer neoplasien

Pathologe

Volumn 33, Issue 2, 2012, Pages 118-123

  Rosamilia, C ^a   Feichter, G ^a   Tzankov, A ^a   Obermann, E C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cervical intraepithelial neoplasia; Cyclin dependent kinase inhibitor p16; Ki 67; Mcm2 protein; Proliferation markers

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; MCM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR MARKER;

ARTICLE; BIOPSY; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLASSIFICATION; FEMALE; HUMAN; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

BIOPSY; CELL CYCLE PROTEINS; CELL PROLIFERATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; KI-67 ANTIGEN; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84863987427     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-011-1549-5     Document Type: Article

References (35)

1. Agoff SN, Lin P, Morihara J et al (2003) p16 (INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16:665-673 (Pubitemid 36871499)
2. Arends MJ, Buckley CH, Wells M (1998) Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 51:96-103 (Pubitemid 28140721)
3. Baak JP, Kruse AJ, Robboy SJ et al (2006) Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol 59:1017-1028 (Pubitemid 44570323)
4. Baldwin P, Laskey R, Coleman N (2003) Translational approaches to improving cervical screening. Nat Rev Cancer 3:217-226 (Pubitemid 37328873)
5. Boulet GA, Horvath CA, Berghmans S, Bogers J (2008) Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 17:810-817 (Pubitemid 351536410)
6. Castle PE, Cox JT, Jeronimo J et al (2008) An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol 111:847-856 (Pubitemid 351482616)
7. Castle PE, Stoler MH, Solomon D, Schiffman M (2007) The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 127:805-815
8. Conesa-Zamora, Domenech-Peris A, Orantes-Casado FJ et al (2009) Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol 132:378-390
9. Cuschieri K, Wentzensen N (2008) Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 17:2536-2545
10. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Arbeitsgemeinschaft Infektiologie und Infektimmunologie in Gynäkologie und Geburtshilfe, Berufsverband der Frauenärzte et al (2008) Prävention, Diagnostik und Therapie der HPV-Infektion und präinvasiver Läsionen des weiblichen Genitale: AWMF 0015/027 (S2k) www.dggg.de/fileadmin/public-docs/ Leitlinien/g-01-04-04-praevention-diagnostik-therapie-hpvinfektion.pdf
11. Duggan MA, Akbari M, Magliocco AM (2006) Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome. Hum Pathol 37:1473-1481 (Pubitemid 44584328)
12. Freeman A, Morris LS, Mills AD et al (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5:2121-2132 (Pubitemid 29399268)
13. Galgano MT, Castle PE, Atkins KA et al (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34:1077-1087
14. Gerdes J, Lemke H, Baisch H et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715 (Pubitemid 14035254)
15. Ishikawa M, Fujii T, Saito M et al (2006) Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 16:347-353
16. Kalof AN, Cooper K (2007) Our approach to squamous intraepithelial lesions of the uterine cervix. J Clin Pathol 60:449-455 (Pubitemid 46867149)
17. Kearsey SE, Labib K (1998) MCM proteins: evolution, properties, and role in DNA replication. Biochim Biophys Acta 1398:113-136 (Pubitemid 28305206)
18. Klaes R, Benner A, Friedrich T et al (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389-1399 (Pubitemid 35239415)
19. Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16 (INK4 A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276-284 (Pubitemid 32225381)
20. Kruse AJ, Baak JP, Helliesen T et al (2002) Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am J Surg Pathol 26:1501-1507 (Pubitemid 35239427)
21. Kruse AJ, Skaland I, Janssen EA et al (2004) Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol 23:100-109 (Pubitemid 38391768)
22. Leong TY, Cooper K, Leong AS (2010) Immunohistology-past, present, and future. Adv Anat Pathol 17:404-418
23. Martin CM, O'Leary JJ (2011) Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol 25:605-615
24. McCluggage WG, Bharucha H, Caughley LM et al (1996) Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J Clin Pathol 49:833-835 (Pubitemid 26338564)
25. Negri G, Bellisano G, Zannoni GF et al (2008) p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol 32:1715-1720
26. Pirog EC, Baergen RN, Soslow RA et al (2002) Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 26:70-75 (Pubitemid 34019994)
27. Quade BJ, Yang A, Wang Y et al (2001) Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 80:24-29 (Pubitemid 32062084)
28. Sanati S, Huettner P, Ylagan LR (2010) Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol 29:79-87
29. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-1505 (Pubitemid 32221899)
30. Tachibana KE, Gonzalez MA, Coleman N (2005) Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 205:123-129 (Pubitemid 40227985)
31. Tsoumpou I, Arbyn M, Kyrgiou M et al (2009) p16 (INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 35:210-220
32. Tzankov A, Went P, Zimpfer A, Dirnhofer S (2005) Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 40:737-744 (Pubitemid 41265824)
33. Wells M, Östör AG, Crum CP et al (2003) Epithelial tumours. In: Tavassoli FA, Devilee P (Hsrg) Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, S 259-290
34. Williams GH, Romanowski P, Morris L et al (1998) Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 95:14932-14937 (Pubitemid 29003734)
35. Hausen H zur (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350 (Pubitemid 37328947)